Side-by-side comparison of AI visibility scores, market position, and capabilities
San Diego net lease REIT (NYSE: O) "Monthly Dividend Company" at 15,621 properties; AFFO $4.19 (+4.8%, 14 consecutive years growth), Spirit Realty $9.3B merger completed Jan 2024, 7.1% acquisition yield.
Realty Income Corporation is a San Diego, California-based net lease real estate investment trust — publicly traded on the New York Stock Exchange (NYSE: O) as an S&P 500 Real Estate component and a member of the S&P 500 Dividend Aristocrats — owning and managing 15,621 commercial properties in the United States, United Kingdom, and Europe under long-term net lease agreements with retail, industrial, and gaming tenants through approximately 650 employees. Realty Income is nicknamed "The Monthly Dividend Company" for its unbroken record of paying monthly dividends to shareholders every month since 1994 and achieving 14 consecutive years of AFFO (Adjusted Funds From Operations) per share growth — in fiscal year 2024, AFFO per share reached $4.19 (+4.8%) and monthly dividends paid per share totaled $3.126 (+2.5%). The company invested $1.7 billion in new properties at a 7.1% initial weighted average cash yield during 2024. Realty Income's most significant recent transaction was the merger with Spirit Realty Capital (completed January 2024, approximately $9.3 billion) — expanding the portfolio from approximately 13,000 to 15,621 properties and adding a significant diversified retail, casual dining, and industrial portfolio that enhanced Realty Income's geographic diversification across the continental US. CEO Sumit Roy leads Realty Income's strategy of growing the net lease portfolio through sale-leaseback transactions with operators seeking to unlock capital from owned real estate while maintaining long-term occupancy.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.